Report forecasts uneven growth in pharmaceutical sales

A new report from the IQVIA Institute for Human Data Science provides insights into several trends in the pharmaceutical and biotech sectors that are emerging this year.

IQVIA, which says that the industry is increasingly turning to the use of real-world evidence and technology to address problems, has produced 10 predictions related to costs, drug development, delivery and more.

Among the report’s predictions are that the US Food and Drug Administration will increase the use of real-world evidence to support regulation of medicines, leading to “more collaborative approaches between life sciences companies and the FDA around areas such as trial design and post-market surveillance.”